• 1. The Third Clinical College of Xinxiang Medical University, Xinxiang, 453003, P. R. China;
  • 2. Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China;
  • 3. Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China;
CHE Guowei, Email: cheguoweixw@126.com
Export PDF Favorites Scan Get Citation

[Abstract]Lung cancer exhibits the highest incidence and mortality rates among malignancies in China. As a critical component of comprehensive lung cancer management, pulmonary rehabilitation (PR) has emerged as a prominent research focus. PR employs multimodal interventions to improve functional capacity and quality of life in lung cancer patients, with applicability across all disease stages. However, challenges persist, including the lack of standardized protocols, uncertainty regarding optimal implementation timing, and suboptimal patient adherence. Technological innovations hold significant potential, and future efforts should prioritize personalized regimens and optimized interventions to advance its widespread clinical adoption.

Copyright © the editorial department of Chinese Journal of Clinical Thoracic and Cardiovascular Surgery of West China Medical Publisher. All rights reserved